[Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments in favor].
The conventional antiarrhythmic treatment of ventricular arrhythmias causing sudden death is the implantable cardioverter defibrillator. Any drug, intervention or device designed to prevent sudden death should be compared in the future in a prospective and randomized way with the implantable cardioverter defibrillator as the standard treatment. The MADIT strategy should be considered as the conventional treatment of the patients with sustained ventricular arrhythmias and of the patients with nonsustained ventricular arrhythmias and depressed left ventricular ejection fraction.